Good Neighbor Pharmacy Network Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2024
Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 81% Above Its Share Price
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
Evercore Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $260
Deutsche Bank Adjusts Price Target on Cencora to $247 From $262, Maintains Buy Rating
Cencora Earnings Preview: What to Expect
Barclays Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $263
Barclays Sticks to Its Buy Rating for Cencora (COR)
Cencora (NYSE:COR) Ticks All The Boxes When It Comes To Earnings Growth
Citi Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $280
Insider Sale: Steven Collis Sells 10,755 Shares of Cencora Inc (COR)
McKesson, Cardinal, Cencora Interested in Buying Private Cancer Clinics - Report
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Why Cencora (COR) Is a Top Value Stock for the Long-Term
Why Cencora (COR) Is Poised to Beat Earnings Estimates Again
Investing in Cencora (NYSE:COR) Five Years Ago Would Have Delivered You a 179% Gain
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
A Closer Look at 4 Analyst Recommendations For Cencora
Baird Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $285
Express News | Baird Maintains Outperform on Cencora, Raises Price Target to $285